Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR
Marie Brevet(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center)
Cited by 207
Related Papers
Therapeutic Potential of NTRK3 Inhibition in Desmoplastic Small Round Cell Tumor
|Clinical Cancer Research|2020|30
Allele-Specific Role of ERBB2 in the Oncogenic Function of EGFR L861Q in EGFR-Mutant Lung Cancers
|Journal of Thoracic Oncology|2020|19